KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Assets By Segment AnnualBreakdown Of AssetsClinics In Active DevelopmentCost Of Revenue BreakdownDeferred RevenueEmployee StatisticsFranchise License Sold AnnualFranchise License Sold AnnuallyGross Margin %Gross ProfitNew Patients Treated AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income (Loss) By SegmentOperating Income (Loss) By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationPatient Visits AnnualProperty And Equipment, Net BreakdownRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Timing Of Transfer Of ServicesRevenue By Timing Of Transfer Of Services %Revenue By Timing Of Transfer Of Services AnnualRevenue By Timing Of Transfer Of Services Annual %Total Clinics In Operation At The End Of The Period
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Joint (JYNT) Gross Profit (2016 - 2025)

Joint (JYNT) has disclosed Gross Profit for 13 consecutive years, with $12.3 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 3.56% to $12.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.3 million through Dec 2025, up 3.0% year-over-year, with the annual reading at $43.7 million for FY2025, 6.02% up from the prior year.
  • Gross Profit hit $12.3 million in Q4 2025 for Joint, up from $10.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $22.9 million in Q3 2022 to a low of -$22.3 million in Q4 2022.
  • Historically, Gross Profit has averaged $11.6 million across 5 years, with a median of $10.8 million in 2023.
  • Biggest five-year swings in Gross Profit: tumbled 239.72% in 2022 and later surged 149.62% in 2023.
  • Year by year, Gross Profit stood at $15.9 million in 2021, then crashed by 239.72% to -$22.3 million in 2022, then soared by 149.62% to $11.0 million in 2023, then rose by 7.95% to $11.9 million in 2024, then rose by 3.56% to $12.3 million in 2025.
  • Business Quant data shows Gross Profit for JYNT at $12.3 million in Q4 2025, $10.6 million in Q3 2025, and $9.8 million in Q2 2025.